13F HOLDINGS REPORT
Pivotal bioVenture Partners Investment Advisor LLC
Quarter ended Q2 2023 · Filed May 12, 2023 · Accession 0001012975-23-000214
Total Value
$242.9M
Positions
11
Other Managers
1
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | KARUNA THERAPEUTICS INC | 48576A100 | 782,008 | $142.0M | 58.49% |
| 2 | VAXCYTE INC | PCVX | 693,039 | $26.0M | 10.70% |
| 3 | INOZYME PHARMA INC | 45790W108 | 3,213,586 | $18.4M | 7.58% |
| 4 | OCULIS HOLDING AG | OCSAW | 2,381,196 | $17.7M | 7.28% |
| 5 | RALLYBIO CORP | RLYB | 2,404,644 | $13.7M | 5.65% |
| 6 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 569,041 | $6.3M | 2.58% |
| 7 | FUSION PHARMACEUTICALS INC | 36118A100 | 1,560,982 | $5.9M | 2.42% |
| 8 | VIGIL NEUROSCIENCE INC | 92673K108 | 560,595 | $5.5M | 2.26% |
| 9 | EXSCIENTIA PLC | 30223G102 | 772,285 | $4.1M | 1.69% |
| 10 | BOLT BIOTHERAPEUTICS INC | BOLT | 1,891,467 | $2.6M | 1.08% |
| 11 | ALIGOS THERAPEUTICS INC | ALGS | 743,215 | $649,570 | 0.27% |